U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech

The U.S. Army's missile stockpile is declining and could take years to replenish, according to Army officials. The Food and Drug Administration is evaluating whether to approve a flu vaccine that uses mRNA technology.

Next story